Virtual Event | May 15, 2025

Unlocking The Potential Of iPSC Therapies In Regenerative Medicine

Source: Cell & Gene

Cell & Gene Chief Editor Erin Harris hosted this Cell & Gene Live featuring Julie G. Allickson, Ph.D., Chief Technology Officer at Mayo Clinic's Center for Regenerative Biotherapeutics, and Erin Kimbrel, Ph.D., President & Head at Astellas Institute for Regenerative Medicine, as they explored the rapidly evolving landscape of induced pluripotent stem cell (iPSC)-based therapies.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)